Skip to main content

Advertisement

Log in

Historical and Current Differences Between Europe and the USA in Sports Cardiology

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Abstract

Purpose of review

The purpose of this review is to provide an update and discuss the underlying current differences between the European and American approaches to sports cardiology.

Recent findings

Neither approach is monolithic but are nuanced in each country and state. Europe has led the way with cardiovascular screening of athletes. Italy, in particular, has mandated countrywide athlete testing since the 1980s. The American approach, given geographic, financial, and socioeconomic constraints, has been more gradual in development, despite similar goals in reducing exercise-induced sudden cardiac death. These approaches have dovetailed over the last decade through combined efforts to standardize the use of ECG screening with the 2017 International Criteria and more recently with emphasis on shared decision-making. Collectively, despite remaining differences, the common goal has improved the safety of sport participation through reduction in false positives and enhanced international collaboration on the management of cardiovascular conditions in athletes.

Summary

While differences remain, close collaboration has led to improved implementation of cardiovascular screening and management of athletes worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Afari ME. The emergence of sports cardiology as a specialty. J Am Coll Cardiol. 03 2017;69(11):1509–1512. https://doi.org/10.1016/j.jacc.2017.02.009.

  2. Skilanglauf HS. Skiwettlauf: Eine medizinische sportstudie. 1899;2:15. https://www.vialibri.net/years/books/98218535/1898-henschen-salomon-eberhard-skidlauf-und-skidwettlauf-skilaufund-skiwettlauf.

  3. Morganroth J, Maron BJ, Henry WL, Epstein SE. Comparative left ventricular dimensions in trained athletes. Ann Intern Med. 1975;82(4):521–4. https://doi.org/10.7326/0003-4819-82-4-521.

    Article  PubMed  CAS  Google Scholar 

  4. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324(5):295–301. https://doi.org/10.1056/NEJM199101313240504.

    Article  PubMed  CAS  Google Scholar 

  5. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339(6):364–9. https://doi.org/10.1056/NEJM199808063390602.

    Article  PubMed  CAS  Google Scholar 

  6. Pelliccia A, Culasso F, Di Paolo FM, Maron BJ. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med. 1999;130(1):23–31. https://doi.org/10.7326/0003-4819-130-1-199901050-00005.

    Article  PubMed  CAS  Google Scholar 

  7. Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G. Athlete’s heart in women. Echocardiographic characterization of highly trained elite female athletes. JAMA. Jul 17 1996;276(3):211–5. https://doi.org/10.1001/jama.276.3.211.

  8. Sharma S, Maron BJ, Whyte G, Firoozi S, Elliott PM, McKenna WJ. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete’s heart and hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40(8):1431–6. https://doi.org/10.1016/s0735-1097(02)02270-2.

    Article  PubMed  Google Scholar 

  9. Sharma S. Athlete’s heart–effect of age, sex, ethnicity and sporting discipline. Exp Physiol. 2003;88(5):665–9. https://doi.org/10.1113/eph8802624.

    Article  PubMed  Google Scholar 

  10. Di Paolo FM, Schmied C, Zerguini YA, et al. The athlete’s heart in adolescent Africans: an electrocardiographic and echocardiographic study. J Am Coll Cardiol. 2012;59(11):1029–36. https://doi.org/10.1016/j.jacc.2011.12.008.

    Article  PubMed  Google Scholar 

  11. Papadakis M, Basavarajaiah S, Rawlins J, et al. Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes. Eur Heart J. 2009;30(14):1728–35. https://doi.org/10.1093/eurheartj/ehp164.

    Article  PubMed  Google Scholar 

  12. Baggish AL, Battle RW, Beckerman JG, et al. Sports cardiology: core curriculum for providing cardiovascular care to competitive athletes and highly active people. J Am Coll Cardiol. 2017;70(15):1902–18. https://doi.org/10.1016/j.jacc.2017.08.055.

    Article  PubMed  Google Scholar 

  13. • La Gerche A, Wasfy MM, Brosnan MJ, et al. The athlete’s heart-challenges and controversies: JACC Focus Seminar 4/4. J Am Coll Cardiol. 2022;80(14):1346–1362. https://doi.org/10.1016/j.jacc.2022.07.014. This recent manuscript discusses the challenges and controversies surrounding the athlete’s heart, providing valuable insights into the unique cardiac adaptations observed in athletes and the implications for their cardiovascular health.

  14. • Tucker WJ, Fegers-Wustrow I, Halle M, Haykowsky MJ, Chung EH, Kovacic JC. Exercise for primary and secondary prevention of cardiovascular disease: JACC Focus Seminar 1/4. J Am Coll Cardiol. 2022;80(11):1091–1106. https://doi.org/10.1016/j.jacc.2022.07.004. This reference highlights the importance of physical activity as a means to improve cardiovascular health and reduce the risk of cardiovascular events.

  15. La Gerche A, Howden EJ, Haykowsky MJ, Lewis GD, Levine BD, Kovacic JC. Heart failure with preserved ejection fraction as an exercise deficiency syndrome: JACC Focus Seminar 2/4. J Am Coll Cardiol. 2022;80(12):1177–91. https://doi.org/10.1016/j.jacc.2022.07.011.

    Article  PubMed  Google Scholar 

  16. Semsarian C, Gray B, Haugaa KH, Lampert R, Sharma S, Kovacic JC. Athletic activity for patients with hypertrophic cardiomyopathy and other inherited cardiovascular diseases: JACC Focus Seminar 3/4. J Am Coll Cardiol. 2022;80(13):1268–83. https://doi.org/10.1016/j.jacc.2022.07.013.

    Article  PubMed  Google Scholar 

  17. • Husaini M, Papadakis M, Grapsa J, Chung EH. Sports cardiology: from prevention to promotion. JACC Case Rep. 2022;4(17):1147–1149. https://doi.org/10.1016/j.jaccas.2022.07.028. This perspective emphasizes the evolution in sports cardiology in optimizing sports participation while considering individual and disease specific characteristics.

  18. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296(13):1593–601. https://doi.org/10.1001/jama.296.13.1593.

    Article  PubMed  CAS  Google Scholar 

  19. Corrado D, Pelliccia A, Bjørnstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(5):516–24. https://doi.org/10.1093/eurheartj/ehi108.

  20. Pelliccia A, Fagard R, Bjørnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422–45. https://doi.org/10.1093/eurheartj/ehi325.

    Article  PubMed  Google Scholar 

  21. Pelliccia A, Heidbuchel H, Corrado D, Borjesson M, Sharma S. ESC Textbook of Sports Cardiology. Press: Oxford Univ; 2019.

    Book  Google Scholar 

  22. •• Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17–96. https://doi.org/10.1093/eurheartj/ehaa605. This comprehensive recent guideline serves as a resource for healthcare professionals involved in the management of athletes with cardiovascular conditions. It incorporates updated evidence to help guide safe exercise and sports participation.

  23. Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardiographic interpretation in athletes: the ‘Seattle criteria.’ Br J Sports Med. 2013;47(3):122–4. https://doi.org/10.1136/bjsports-2012-092067.

    Article  PubMed  Google Scholar 

  24. Drezner JA, Sharma S, Baggish A, et al. International criteria for electrocardiographic interpretation in athletes: consensus statement. Br J Sports Med. 2017;51(9):704–31. https://doi.org/10.1136/bjsports-2016-097331.

    Article  PubMed  Google Scholar 

  25. Thompson PD, Funk EJ, Carleton RA, Sturner WQ. Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA. 1982;247(18):2535–8.

    Article  PubMed  CAS  Google Scholar 

  26. Maron BJ, Chaitman BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109(22):2807–16. https://doi.org/10.1161/01.CIR.0000128363.85581.E1.

    Article  PubMed  Google Scholar 

  27. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2008;52(24):1990–6. https://doi.org/10.1016/j.jacc.2008.08.055.

  28. Baggish AL, Ackerman MJ, Putukian M, Lampert R. Shared decision making for athletes with cardiovascular disease: practical considerations. Curr Sports Med Rep. 2019;18(3):76–81. https://doi.org/10.1249/JSR.0000000000000575.

    Article  PubMed  Google Scholar 

  29. Johri AM, Poirier P, Dorian P, et al. Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position statement on the cardiovascular screening of competitive athletes. Can J Cardiol. 2019;35(1):1–11. https://doi.org/10.1016/j.cjca.2018.10.016.

    Article  PubMed  Google Scholar 

  30. Link MS, Estes NAM, Maron BJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 13: Commotio Cordis: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2439–43. https://doi.org/10.1016/j.jacc.2015.09.045.

    Article  PubMed  Google Scholar 

  31. Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2362–71. https://doi.org/10.1016/j.jacc.2015.09.035.

    Article  PubMed  Google Scholar 

  32. Levine BD, Stray-Gundersen J. The medical care of competitive athletes: the role of the physician and individual assumption of risk. Med Sci Sports Exerc. 1994;26(10):1190–2.

    Article  PubMed  CAS  Google Scholar 

  33. Maron BJ, Nishimura RA, Maron MS. Shared decision-making in HCM. Nat Rev Cardiol. 2017;14(3):125–6. https://doi.org/10.1038/nrcardio.2017.6.

    Article  PubMed  Google Scholar 

  34. Mitten MJ. Team physicians and competitive athletes: allocating legal responsibility for athletic injuries, 55 U. Pitt L Rev. 1993;129

  35. Mitten MJ, Zipes DP, Maron BJ, Bryant WJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 15: legal aspects of medical eligibility and disqualification recommendations: a scientific statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2447–50. https://doi.org/10.1016/j.jacc.2015.09.047.

    Article  PubMed  Google Scholar 

  36. Husaini M, Kline KP, Chukumerije M, Emery MS, Martinez MW, Chung EH. Sports cardiology: the transition of fellow-in-training to early career physician. JACC Case Rep. 2022;4(17):1143–6. https://doi.org/10.1016/j.jaccas.2022.04.011.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Kim JH, Martinez MW, Phelan DM, et al. ACC council statement on sudden cardiac arrest during monday night football. https://www.acc.org/Latest-in-Cardiology/Articles/2023/01/04/16/14/ACC-Council-Statement-on-Sudden-Cardiac-Arrest-During-Monday-Night-Football. Accessed 5 May 2023.

  38. Husaini M, Chung EH. Themes from the first sports cardiology focused issue of JACC: case reports. ACC.org. https://www.acc.org/latest-in-cardiology/articles/2022/10/24/11/46/themes-from-the-first-sports-cardiology-focused-issue-of-jacc-case-reports. Accessed 5 May 2023.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mustafa Husaini MD, MBA.

Ethics declarations

Conflict of interest

Dr. Husaini reports Speakers Bureau for Bristol Meyers Squibb. The other authors have nothing to disclose.

Human and animal rights and informed consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Husaini, M., Pelliccia, A. & Froelicher, V. Historical and Current Differences Between Europe and the USA in Sports Cardiology. Curr Treat Options Cardio Med 25, 629–638 (2023). https://doi.org/10.1007/s11936-023-01017-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-023-01017-z

Keywords

Navigation